High court impasse frustrates immigrant families yearning to 'come out of the shadows'

High court impasse frustrates immigrant families yearning to 'come out of the shadows'

Immigrants and their advocates in our region are reacting with with anger and sadness to a tie decision by the Supreme Court, which blocks the Obama administration's efforts to shield as many as 5 million undocumented people

The Pulse

Why don't young doctors want to work in primary care?

Why don't young doctors want to work in primary care?

Half the money and none of the respect, a first-year resident says no wonder new doctors aren't choosing to be generalists.

Crossing choir presents 'Seven Responses' to sacred sorrow of baroque oratorio

Crossing choir presents 'Seven Responses' to sacred sorrow of baroque oratorio

This weekend, a classic oratorio about the body parts of Jesus will get a modern update by a Philadelphia choir.

Top stories from NewsWorks, delivered to your inbox.

Format:
NewsWorks is supported by
Discussion
After Britain's E.U. exit, maybe there’s light at the end of the Chunnel
EssayWorks

After Britain's E.U. exit, maybe there’s light at the end of the Chunnel

Well, they've done it: Defying torrential rain and the predictions of the pundits — including bookmakers caught flat-footed offering odds of 5-1 against Britain's exit from the European Union hours before the vote — some 4

EssayWorks

The Philadelphia Zoo is not your mother's zoo

When the silverback gorilla Harambe was killed in May at the Cincinnati Zoo, I thought of Massa, the 400-pound gorilla at the Philadelphia Zoo, whom my mother claimed fell in love with her.

Weekdays at 6 p.m. on WHYY 90.9 FM

'Brexit' polling: What comes next?

'Brexit' polling: What comes next?

Britain's historic vote to the leave the European Union has the world wondering: What comes next? NewsWorks Tonight's Dave Heller spoke with honorary U.K. consul in Philadelphia, Oliver Franklin, for answers.

Fridays at 9 a.m. on WHYY 90.9 FM
Tough times for Silicon Valley’s diagnostic wunderkind and her multi-billion dollar company, Theranos

Tough times for Silicon Valley’s diagnostic wunderkind and her multi-billion dollar company, Theranos

The company is under scrutiny from the Securities and Exchange Commission and the Food and Drug Administration, largely due to reporting that began last October, by the Wall Street Journal's investigative reporter John

NewsWorks is supported by

NewsWorks is supported by
Your browser is out-of-date!

Some features of this website (and others) may not work correctly with Internet Explorer 8 and below. Click below and we'll show you your upgrade options (they're free). -your friends at NewsWorks. Update my browser now

×